Furthermore, this NF-kB pathway downregulation, and the fact that AGR2 can inhibit p53 activity, suggest that AGR2 prevents both pro-death UPR-mediated apoptosis and inflammation, ultimately promoting tumor cell survival and proliferation. Here, NFKB1 is linked to neoplasm.